David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec 1;5(6):935-42.
Kubin M, Britt D, Trudeau E, Fugl-Meyer A, Gondek K. Patient and partner treatment satisfaction scale (TSS) in erectile dysfunction. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 2003. Barcelona, Spain.
Britt D, Kubin M, Keininger D, Trudeau E, Sagnier P, Beneke M. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. J Sex Med. 2003 Oct;25(Suppl 5):S180.
Britt DM, Kubin M, Keininger D, Trudeau E, Sagnier P, Fugl-Meyer A. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. Poster presented at the 2nd International Consultation on Erectile and Sexual Dysfunctions; June 2003.
Britt D, Kubin M, Keininger D, Trudeau E, Sagnier P, Fugl-Meyer A. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. Pharmacotherapy. 2003 Jun;23(10):132.
Baldus T, Nehra A, Brock G, Britt DM. Influence of vardenafil, a potent, highly selective phosphodiesterase-5 inhibitor on improving erectile function and depressive symptomatology in patients with erectile dysfunction secondary to radical nerve-sparing prostatectomy. Poster presented at the 31st Annual Meeting of the American Academy of Physician Assistants; May 2003.